Richard L. Jackson
President at Richard Jackson Associates LLC
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Edward A. Taylor | M | 81 |
Biomira, Inc.
 Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 13 years |
| Christopher Henney | M | 83 |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 13 years |
| Robert L. Kirkman | M | 75 |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 10 years |
| W. Vickery Stoughton | M | 78 |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 18 years |
| Scott Myers | M | 57 | 2 years | |
| S. Robert Blair | M | - |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 15 years |
| Michael C. Welsh | M | 81 |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 21 years |
| Julia Eastland | F | 59 | 8 years | |
| Douglas Williams | M | 66 | 4 years | |
| Steven James | M | 66 | 3 years | |
| T. McPherson | M | 85 |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 15 years |
| R. Rao Koganty | M | 81 |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 22 years |
| Shashi Karan | M | 70 | 2 years | |
| Gary W. Christianson | M | 69 |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 11 years |
| Diana Hausman | M | 61 | 7 years | |
| Ted Love | M | 65 | 5 years | |
| David R. Bethune | M | 83 |
Atrix Laboratories, Inc.
 Atrix Laboratories, Inc. Pharmaceuticals: OtherHealth Technology Atrix Laboratories, Inc. develops and manufactures dental, medical, and veterinary products for drug delivery application | 5 years |
| Dan Spiegelman | M | 65 | 10 years | |
| D. Kirkpatrick | M | 67 |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 2 years |
| Jay Venkatesan | M | 52 | 1 years | |
| Scott Robert Peterson | M | 62 | 9 years | |
| Bill Wickson | M | - |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | - |
| Guy Cipriani | M | 54 | 5 years | |
| David Shin | M | - | 2 years | |
| Gwen A. Fyfe | M | 72 | 2 years | |
| Guy Ely | M | 71 |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | - |
| Jane H. Tulloch | F | - |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | - |
| Marilyn Olson | F | - |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 18 years |
| Ronald J. Helmhold | M | - |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 11 years |
| Robert D. Aubrey | M | - |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 17 years |
| Stephen K. Burley | M | 66 | - | |
| George J. Vuturo | M | 74 |
Atrix Laboratories, Inc.
Atrix Laboratories, Inc. Pharmaceuticals: OtherHealth Technology Atrix Laboratories, Inc. develops and manufactures dental, medical, and veterinary products for drug delivery application | 3 years |
| Sheila Moriber Katz | M | - |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | - |
| Eric Edward Baker | M | - |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | - |
| Mark Nathan Lampert | M | 56 | 1 years | |
| Fred Hassan | M | 78 |
Wyeth-Ayerst Laboratories
| 4 years |
| David W. Osborne | M | 62 |
Atrix Laboratories, Inc.
Atrix Laboratories, Inc. Pharmaceuticals: OtherHealth Technology Atrix Laboratories, Inc. develops and manufactures dental, medical, and veterinary products for drug delivery application | 4 years |
| Marc L. Lesnick | M | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 29 | 76.32% |
| Canada | 18 | 47.37% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Richard L. Jackson
- Personal Network
